Systemic Fluoride Bioavailability From Toothpastes Containing Calcium Carbonate or Silica as Abrasives

Sponsor
University of Campinas, Brazil (Other)
Overall Status
Completed
CT.gov ID
NCT01571050
Collaborator
(none)
20
1
5
11
1.8

Study Details

Study Description

Brief Summary

The risk of dental fluorosis development is related to the systemic exposure to fluoride during enamel formation. Currently, diet and fluoride toothpastes are the main sources of fluoride to children at the age-risk for fluorosis development. However, when estimating the risk of fluorosis from toothpaste inadvertently ingested, it has not been considered the systemic fluoride bioavailability. Since some toothpaste formulations may contain part of fluoride as insoluble salts, the hypothesis behind this study is that only soluble fluoride in toothpastes would be absorbed when they are inadvertently ingested. To test that, adult volunteers will ingest a standardized dose of total fluoride from commercially available toothpastes, which present different concentrations of soluble fluoride. Fluoride systemic bioavailability will be assessed by the release of fluoride in saliva up to 3 hours after ingestion (as an indicator of blood fluoride) and by urinary fluoride excretion.

Condition or Disease Intervention/Treatment Phase
  • Drug: Purified water
  • Drug: Fresh MFP/CaCO3 toothpaste
  • Drug: Fresh NaF/SiO2 toothpaste
  • Drug: Aged NaF/SiO2 toothpaste
  • Drug: Aged MFP/CaCO3 toothpaste
Phase 1

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Investigator)
Primary Purpose:
Prevention
Study Start Date :
Jan 1, 2011
Actual Primary Completion Date :
Aug 1, 2011
Actual Study Completion Date :
Dec 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: Fresh NaF/SiO2 toothpaste

Drug: Fresh NaF/SiO2 toothpaste
Ingestion of 49.5 mg of a fresh toothpaste containing 1100 ppm total fluoride per kg body weight, diluted in 30 mL of purified water, to provide a total intake of 49.5 ug of fluoride/kg body weight.

Placebo Comparator: Purified water

Drug: Purified water
Ingestion of 30 mL of purified water

Experimental: Aged NaF/SiO2 toothpaste

Drug: Aged NaF/SiO2 toothpaste
Ingestion of 49.5 mg of a toothpaste containing 1100 ppm total fluoride per kg body weight, diluted in 30 mL of purified water, to provide a total intake of 49.5 ug of fluoride/kg body weight. The toothpaste had been previously aged to simulate one year storage at room temperature.

Experimental: Fresh MFP/CaCO3 toothpaste

Drug: Fresh MFP/CaCO3 toothpaste
Ingestion of 31.9 mg of a fresh toothpaste containing 1450 ppm total fluoride per kg body weight, diluted in 30 mL of purified water, to provide a total intake of 49.5 ug of fluoride/kg body weight.

Experimental: Aged MFP/CaCO3 toothpaste

Drug: Aged MFP/CaCO3 toothpaste
Ingestion of 31.9 mg of a toothpaste containing 1450 ppm total fluoride per kg body weight, diluted in 30 mL of purified water, to provide a total intake of 49.5 ug of fluoride/kg body weight. The toothpaste had been previously aged to simulate one year storage at room temperature.

Outcome Measures

Primary Outcome Measures

  1. Area under the curve of salivary fluoride concentration versus time after toothpaste ingestion [3 hours]

    Saliva will be collected before and up to 3 hours after ingestion of the toothpastes or negative control. Collections (during 3 min) will be made at 0 (immediately before ingestion), 15, 30, 45, 60, 120 and 180 min after ingestion.

Secondary Outcome Measures

  1. Maximum concentration of fluoride in saliva after toothpaste ingestion [3 hours]

    Saliva collected up to 3 hours after the ingestion of toothpastes or negative control will be analyzed for fluoride concentration and the maximum concentration during this period will be recorded.

  2. Urinary fluoride excretion (24-h) after toothpaste ingestion [48 hours]

    Urine will be collected for the 24 hours preceeding the ingestion of the toothpastes or negative control and for the 24 hours after the ingestion. The difference in the amount of fluoride excreted in 24h urine samples, after or before the treatments, will be calculated.

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Good general health

  • Good oral health

  • Normal salivary flow rate

Exclusion Criteria:
  • Gastric disorders

  • Renal disorders

Contacts and Locations

Locations

Site City State Country Postal Code
1 Piracicaba Dental School, University of Campinas Piracicaba SP Brazil 13414903

Sponsors and Collaborators

  • University of Campinas, Brazil

Investigators

  • Principal Investigator: Livia MA Tenuta, PhD, Piracicaba Dental School, University of Campinas

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Livia Maria Andaló Tenuta, Assistant Professor, Biochemistry and Cariology, University of Campinas, Brazil
ClinicalTrials.gov Identifier:
NCT01571050
Other Study ID Numbers:
  • FOPFBioavailability2011
First Posted:
Apr 4, 2012
Last Update Posted:
Apr 4, 2012
Last Verified:
Apr 1, 2012
Keywords provided by Livia Maria Andaló Tenuta, Assistant Professor, Biochemistry and Cariology, University of Campinas, Brazil
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 4, 2012